Internal Medicine, Hematology & Oncology · Christiansburg, VA
NPI
1962478164
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2955 Market St, Suite 5
Christiansburg, VA, 24073
Phone (540) 381-5291
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.8M
161,135 services
Medicare patients, 2024
939
Average age 75
Drug cost, 2024
$5.8M
2,059 prescriptions
Company payments, 2025
$5,951
From 38 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jerome H Goldschmidt Jr. was code J1439 (injection, ferric carboxymaltose, 1 mg), 42,750 times for 34 patients. In total Jerome H Goldschmidt Jr. billed 161,135 services in 177 codes, and Medicare paid $2.8M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-11-02.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 42,750 | 34 | $0.87 | $37K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 11,300 | 21 | $44.55 | $503K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 9,360 | 13 | $39.26 | $367K |
| J9267 Injection, paclitaxel, 1 mg | Office | 5,470 | 13 | $0.08 | $442 |
| J0185 Injection, aprepitant, 1 mg | Office | 4,160 | 18 | $1.35 | $5,635 |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 3,410 | 16 | $2.20 | $7,518 |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 2,112 | 14 | $37.08 | $78K |
| 85025 Blood Count | Office | 1,902 | 539 | $7.61 | $14K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,800 | 18 | $15.93 | $29K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,610 | 63 | $0.09 | $144 |
| J0897 Injection, denosumab, 1 mg | Office | 1,560 | 19 | $20.35 | $32K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 1,350 | 47 | $0.25 | $339 |
| 80053 Clinical Chemistry | Office | 1,176 | 432 | $10.35 | $12K |
| 36415 Venipuncture Blood Collection | Office | 1,081 | 441 | $8.65 | $9,351 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 520 | 28 | $0.70 | $362 |
By year: 2022 $3.2M for 198,395 services; 2023 $2.6M for 185,433 services; 2024 $2.8M for 161,135 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,902 | 539 | $7.61 | $14K |
| 80053 Clinical Chemistry | 1,176 | 432 | $10.35 | $12K |
| 36415 Venipuncture Blood Collection | 1,081 | 441 | $8.65 | $9,351 |
| 82728 Clinical Chemistry | 422 | 187 | $13.36 | $5,638 |
| 82784 Immunoassay | 384 | 57 | $9.11 | $3,500 |
| 83540 Clinical Chemistry | 354 | 175 | $6.34 | $2,244 |
| 83550 Clinical Chemistry | 354 | 175 | $8.57 | $3,034 |
| 83615 Clinical Chemistry | 255 | 141 | $5.92 | $1,510 |
| 83521 Immunoassay | 223 | 51 | $16.92 | $3,774 |
| 84153 Clinical Chemistry | 104 | 41 | $18.02 | $1,874 |
Medicare prescription drug claims, 2024
In 2024, the drug Jerome H Goldschmidt Jr. prescribed most often to Medicare patients was Anastrozole, with 182 prescriptions and refills. In total Jerome H Goldschmidt Jr. wrote 2,059 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 182 | 403 | 49 | $2,906 |
| Prednisone Generic | 128 | 156 | 33 | $630 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 85 | 85 | 27 | $2,080 |
| Lenalidomide Generic | 81 | 81 | Under 11 | $984K |
| Letrozole Generic | 75 | 144 | 16 | $1,080 |
| Abiraterone Acetate Generic | 64 | 64 | 11 | $21K |
| Jakafi Ruxolitinib Phosphate | 59 | 59 | Under 11 | $1.0M |
| Gabapentin Generic | 58 | 60 | 19 | $469 |
| Ondansetron Hcl Generic | 55 | 55 | 29 | $3,326 |
| Tamoxifen Citrate Generic | 53 | 92 | 13 | $560 |
| Hydroxyurea Generic | 50 | 104 | 13 | $1,104 |
| Oxycodone Hcl Generic | 48 | 48 | 18 | $1,323 |
| Eliquis Apixaban | 44 | 62 | 11 | $36K |
| Lorazepam Generic | 43 | 43 | Under 11 | $114 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 41 | 41 | Under 11 | $886 |
Brand drugs: 388 claims; generic drugs: 1,671 claims; opioid claims: 289.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jerome H Goldschmidt Jr. $5,951 ($5,951 in general payments such as food, travel and fees) from 38 companies. The largest payer was Exelixis Inc. with $3,632.
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. EXEL | 10 | $3,632 |
| Incyte Corporation INCY | 2 | $1,120 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $160 |
| Genentech USA, Inc. ROG.SW | 5 | $150 |
| Merck Sharp & Dohme LLC MRK | 3 | $76.67 |
| Pfizer Inc. PFE | 3 | $68.89 |
| Genzyme Corporation SNY | 2 | $63.24 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $60.01 |
| Abbvie Inc. ABBV | 2 | $56.15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.